These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34231055)

  • 1. Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping.
    Fehr A; Werenicz S; Trocchi P; Falk M; Friedrich RE; Stammler A; Stang A; Oesterling F; Khil L; Stenman G; Böcker W; Tiemann K; Löning T
    Virchows Arch; 2021 Nov; 479(5):975-985. PubMed ID: 34231055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis.
    Cipriani NA; Lusardi JJ; McElherne J; Pearson AT; Olivas AD; Fitzpatrick C; Lingen MW; Blair EA
    Am J Surg Pathol; 2019 Jul; 43(7):885-897. PubMed ID: 31021855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
    Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
    Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
    Nakano S; Okumura Y; Murase T; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Kawakita D; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
    Histopathology; 2022 Mar; 80(4):729-735. PubMed ID: 34657306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.
    Nakayama T; Miyabe S; Okabe M; Sakuma H; Ijichi K; Hasegawa Y; Nagatsuka H; Shimozato K; Inagaki H
    Mod Pathol; 2009 Dec; 22(12):1575-81. PubMed ID: 19749740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.
    Okumura Y; Nakano S; Murase T; Ueda K; Kawakita D; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
    Cancer Sci; 2020 Nov; 111(11):4195-4204. PubMed ID: 32860299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
    Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
    Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma.
    Saade RE; Bell D; Garcia J; Roberts D; Weber R
    JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):234-40. PubMed ID: 26796488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
    Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
    Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
    Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
    Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
    Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
    Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Profiling of Salivary Oncocytic Mucoepidermoid Carcinomas Helps to Resolve Differential Diagnostic Dilemma With Low-grade Oncocytic Lesions.
    Skálová A; Agaimy A; Stanowska O; Baneckova M; Ptáková N; Ardighieri L; Nicolai P; Lombardi D; Durzynska M; Corcione L; Laco J; Koshyk O; Žalud R; Michal M; Vanecek T; Leivo I
    Am J Surg Pathol; 2020 Dec; 44(12):1612-1622. PubMed ID: 33002921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.
    Birkeland AC; Foltin SK; Michmerhuizen NL; Hoesli RC; Rosko AJ; Byrd S; Yanik M; Nor JE; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
    Oral Oncol; 2017 May; 68():5-8. PubMed ID: 28438292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
    Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells.
    Chen Z; Lin S; Li JL; Ni W; Guo R; Lu J; Kaye FJ; Wu L
    Oncogene; 2018 Apr; 37(14):1885-1895. PubMed ID: 29353885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status.
    Nakano T; Yamamoto H; Hashimoto K; Tamiya S; Shiratsuchi H; Nakashima T; Nishiyama K; Higaki Y; Komune S; Oda Y
    Histopathology; 2013 Sep; 63(3):378-92. PubMed ID: 23855785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of histological grading methods in mucoepidermoid carcinoma of minor salivary glands.
    Qannam A; Bello IO
    Indian J Pathol Microbiol; 2016; 59(4):457-462. PubMed ID: 27721274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAML2 rearrangement in primary pulmonary mucoepidermoid carcinoma and the correlation with FLT1 expression.
    Zhu F; Wang W; Hou Y; Shi J; Liu Z; He D; Bai C; Li S; Jiang L
    PLoS One; 2014; 9(4):e94399. PubMed ID: 24714697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.
    Seethala RR; Dacic S; Cieply K; Kelly LM; Nikiforova MN
    Am J Surg Pathol; 2010 Aug; 34(8):1106-21. PubMed ID: 20588178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
    Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.